Key facts
- This page summarizes Christopher M. Murphy's Form 4 filing for ANAPTYSBIO, INC (ANAB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 May 2026, 17:48.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
Footnote F2
The RSUs vests as to 25% of the total RSUs annually commencing on May 11, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.